Table 5 Extent of reliable change at T2 and T3

From: A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

 

T2

T3

 

Chemo

Nonchemo

Control

Chemo

Nonchemo

control

Decline on ⩾2 measures

17 20%

11 25.6%

9 18.4%

15 18.1%

6 14.3%

5 10.6%

Improve on ⩾2 measures

19 22.4%

7 16.3%

8 16.3%

27 32.1%

13 30.2%

7 14.6%

Back to article page